Astrana Health Ownership

ASTH Stock   44.81  1.56  3.61%   
Astrana Health holds a total of 45.65 Million outstanding shares. Astrana Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2001-09-30
Previous Quarter
48 M
Current Value
48.2 M
Avarage Shares Outstanding
16.5 M
Quarterly Volatility
20.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Astrana Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Astrana Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The Astrana Health's current Dividend Yield is estimated to increase to 0.04, while Dividends Paid is forecasted to increase to (59 M). The Astrana Health's current Common Stock Shares Outstanding is estimated to increase to about 49.4 M. The Astrana Health's current Net Income Applicable To Common Shares is estimated to increase to about 59.2 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Astrana Stock Ownership Analysis

About 24.0% of the company shares are held by company insiders. The book value of Astrana Health was presently reported as 14.75. The company had not issued any dividends in recent years. Astrana Health had 1:10 split on the 27th of April 2015. For more info on Astrana Health please contact Brandon Sim at 626 282 0288 or go to https://www.astranahealth.com.

Astrana Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Astrana Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Astrana Health backward and forwards among themselves. Astrana Health's institutional investor refers to the entity that pools money to purchase Astrana Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Northern Trust Corp2024-09-30
424.1 K
Morgan Stanley - Brokerage Accounts2024-09-30
342.6 K
Fort Washington Investment Advisors Inc2024-09-30
299.8 K
Bank Of New York Mellon Corp2024-09-30
268.7 K
Goldman Sachs Group Inc2024-09-30
258.9 K
Royal Bank Of Canada2024-09-30
254.6 K
Bellevue Group Ag2024-09-30
254.2 K
Amvescap Plc.2024-09-30
241.8 K
Atria Wealth Solutions, Inc.2024-09-30
237.4 K
Blackrock Inc2024-06-30
6.4 M
Vanguard Group Inc2024-09-30
4.7 M
Note, although Astrana Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Astrana Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Astrana Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Astrana Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Astrana Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Astrana Health Outstanding Bonds

Astrana Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Astrana Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Astrana bonds can be classified according to their maturity, which is the date when Astrana Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Astrana Health Corporate Filings

F4
26th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10Q
12th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
15th of July 2024
Other Reports
ViewVerify

Currently Active Assets on Macroaxis

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
1.3
Revenue Per Share
36.415
Quarterly Revenue Growth
0.375
Return On Assets
0.0449
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.